Biocept, Inc.
BIOC · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,631 | -$7,144 | -$18,522 | -$5,544 |
| Dep. & Amort. | $370 | $614 | $438 | $407 |
| Deferred Tax | $0 | -$336 | $0 | $0 |
| Stock-Based Comp. | $209 | $316 | $0 | $462 |
| Change in WC | $1,694 | $20 | $13,838 | $378 |
| Other Non-Cash | -$1,728 | $336 | $141 | $222 |
| Operating Cash Flow | -$3,086 | -$6,194 | -$4,242 | -$4,075 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$97 | -$91 | -$136 | -$356 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $75 | $0 | $0 | $0 |
| Investing Cash Flow | -$22 | -$91 | -$136 | -$356 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $3,558 | $396 | $1 | $145 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,967 | $162 | -$746 | -$476 |
| Financing Cash Flow | $2,967 | $162 | -$746 | -$476 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$141 | -$6,123 | -$5,124 | -$4,907 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,774 | $12,897 | $18,021 | $22,928 |
| End Cash | $6,633 | $6,774 | $12,897 | $18,021 |
| Free Cash Flow | -$3,183 | -$6,285 | -$4,378 | -$4,431 |